Skip to main content

Demografía y Familias

FJC2019-039314-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva Formación
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre CENTRE D ESTUDIS DEMOGRÀFICS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Cumulative COVID-19 incidence indicators should account for the population-at-risk dynamics

  • Masjuan, Pere
  • Trias-Llimós, Sergi
  • Rojas, Camilo
  • Prakash, Arul
  • Gullón, Pedro
  • Tobías, Aurelio
  • López-Gay, Antonio
Risk estimators for COVID-19 propagation based on the incidence rate of new cases can be misleading as they usually fail to account for the fraction of population immunized by infection or vaccination.This misconception yields different incidence rates, as we illustrate using the daily number of COVID-19 reported cases in Spain during the pre-vaccine period, between 15/01/2020 and 11/07/2021. An increase in the incidence rate of about 7% is found when properly accounting for the population at risk. Our results demonstrate that accounting for dynamic changes to the immunized fraction of the population is necessary for accurate risk estimation. We hope that our findings can lead to more effective strategies for pandemic response., The authors affiliated to CED acknowledge the support of the CERCA institution, Centres de Recerca de Catalunya. AL acknowledges the support from the Talent Research Program (Universitat Autònoma de Barcelona). PM, CR, and AP acknowledge the support from the Ajuntament de Barcelona. STL acknowledges research funding from the Juan de la Cierva-Formación (Spanish Ministry of Science and Innovation, FJC-2019-039314-I). PG is supported by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI18/00782 and PI21/01868) and by Comunidad de Madrid (Línea de actuación “Estímulo a la Investigación de Jóvenes Doctores”, CM/JIN/2021-028). AT was supported by MCIN/AEI/10.13039/501100011033 (grant CEX2018-000794-S)., No